Perceptions of participation in a phase I, II, or III clinical trial among African American patients with cancer: What do refusers say?

Journal of Oncology Practice

Volumn 9, Issue 6, 2013, Pages 287-293

  Brown, Richard F ^a   Cadet, Debbie L ^a   Houlihan, Robert H ^a   Thomson, Maria D ^a   Pratt, Emily C ^a   Sullivan, Amy ^a   Siminoff, Laura A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; DECISION MAKING; DECISION SUPPORT SYSTEM; ETHNIC GROUP; EXPERIENCE; FEMALE; HEALTH STATUS; HUMAN; INFORMATION SEEKING; MALE; MIDDLE AGED; NEOPLASM; PATIENT; PATIENT PARTICIPATION; PERCEPTION; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); QUESTIONNAIRE; REFUSAL TO PARTICIPATE; SEMI STRUCTURED INTERVIEW; SOCIAL PSYCHOLOGY;

ADULT; AFRICAN AMERICANS; AGED; ATTITUDE TO HEALTH; CLINICAL TRIALS AS TOPIC; CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT SELECTION; QUESTIONNAIRES;

EID: 84896295082     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2013.001039     Document Type: Article

References (60)

1. Ellis P, Butow PN, Tattersall MHN, et al (eds): Accrual to clinical trials in breast cancer. Annual Scientific Meeting of the Clinical Oncological Society of Australia, Brisbane, Australia, 1996
2. Avis NE, Smith KW, Link CI, et al: Factors associated with participation in breast cancer clinical trials J Clin Oncol 24:1860-1867, 2006 (Pubitemid 46638984)
3. Lara PN Jr, Higdon N, Lim N, et al: Prospective evaluation of clinical trial accrual patterns: Identifying potential barriers to enrolment. J Clin Oncol 19:1728-1733, 2001 (Pubitemid 32230874)
4. Robinson JM, Trochim WM: An examination of community members', researchers' and heath professionals' perceptions of barriers to minority participation in medical research: An application of concept mapping. EthnHealth 12:521-39, 2007 (Pubitemid 350058912)
5. Bartlett EE, Grayson M, Barker R, et al: The effects of physician communications skills on patient satisfaction, recall, and adherence. J Chron Dis 37:755-764, 1984 (Pubitemid 15180635)
6. Britton A, McKee M, Black N, et al: Threats to the applicability of randomised trials, exclusions and selective participation. J Health Serv Res Pol 4:112-121, 1999 (Pubitemid 29186862)
7. Ford JG, Howerton MW, Lai GY, et al: Barriers to recruiting underrepresented populations in cancer clinical trials:a systemtic review. Cancer 112:228-242, 2007
8. Goss W, Lopez AM, Brown CL, et al: American Society of Clinical Oncology policy statement: Disparities in cancer care. J Clin Oncol 27:2882-2884, 2009
9. Corbie Smith G, Thomas SB, St George DM: Distrust, race and research. Arch Int Med 162:2458-2463, 2002
10. Fouad MN: Enrolment of minorities in clinical trials: Did we overcome the barriers? Contemp Clin Trials 30:103-104, 2009
11. Barofsky I, Sugarbaker PH: Determinants of patient non participation in randomised clinical trials for treatment of sarcomas. Cancer Clin Trials 2:237-246, 1979 (Pubitemid 10038651)
12. Adams-Campbell LL, Ahaghotu C, Gaskins M, et al: Enrolment of African Americans onto clinical treatment trials: Study design barriers. J Clin Oncol 22: 730-734, 2004 (Pubitemid 41095078)
13. Gross CP, Filardo G, Mayne ST, et al: The impact of sociodemographic status and race on trial participation for older women with breast cancer. Cancer 103: 483-491, 2005
14. McCaskill-Stevens W, McKinney MM, Whitman CG, et al: Increasing minority participation in cancer clinical trials: The Minority-Based Community Clinical Oncology Program experience. J Clin Oncol 23:5247-5254, 2005 (Pubitemid 46224036)
15. Mills EJ, Seely D, Rachlis B, et al: Barriers to participation in clinical trials of cancer: A meta analysis and systematic review of patient-reported factors. Lancet Oncol 7:141-148, 2006 (Pubitemid 43159500)
16. Paskett ED, Katz ML, DeGraffinreid CR, et al: Participation in cancer trials; recruiting underserved populations. Clin Adv Hematol Oncol 1:607-613, 2003
17. Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP: Participation in surgical oncology trials: Gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol 14:3328-3334, 2007 (Pubitemid 350160101)
18. Go RS, Frisby KA, Lee JA, et al: Clinical trial accrual among new cancer patients at a community based cancer center. Cancer 106:426-433, 2006 (Pubitemid 43100454)
19. Penberthy L, Brown R, Puma F, et al: Automated matching software for clinical trials eligibility; measuring efficiency and flexibility. Contemp Clin Trials 31:207-217, 2010
20. Penberthy L, Brown RF, Wilson-Genderson M, et al: Barriers to therapeutic clinical trials enrollment: Differences between African-American and White cancer patients identified at the time of eligibility assessment. Clin Trials (in press) doi: 10.1177/1740774512458992
21. Cassileth BR, Zupkis RV, Sutton-Smith K, et al: Information and participation preferences among cancer patients. Ann Intern Med 92:832-836, 1980 (Pubitemid 10124374)
22. Degner LF, Sloan JA, Venkatech P: The Control Preferences Scale. Can J Nurs Res 29:21-43, 1997 (Pubitemid 127473357)
23. Roth AJ, Kornblith AB, Batel-Copel L, et al: Rapid screening for psychologic distress in men with prostate carcinoma: A pilot study. Cancer 82:1904-1908, 1998 (Pubitemid 28208646)
24. Sherbourne CD, Stewart AL: The MOS social support survey. Soc Sci Med 32:705-714, 1991
25. Wolf MS, Chang CH, Davis T, et al: Development and validation of the Communication and Attitudinal Self-Efficacy scale for cancer (CASE-cancer). Patient Educ Couns 57:333-341, 2005. (Pubitemid 40694014)
26. Holmes-Rovner M, Kroll J, Schmitt N, et al: Patient satisfaction with health care decisions: The Satisfaction with Decision Scale. Med Dec Making 16:58-64, 1994
27. Brehaut JC, O'Connor AM, Wood TJ, et al: Validation of a Decision Regret Scale. Med Dec Making 23:281-292, 2003 (Pubitemid 36899094)
28. Glaser BJ, Strauss AL: The Discovery of Grounded Theory: Strategies for Qualitative Research. New York, NY, Adline Publishing Company, 1967
29. Miles MV, Huberman MA: Qualitative Data Analysis: A Sourcebook of New Methods. London, United Kingdom, Sage, 1984
30. Guest G, Bunce A, Johnson L: How many interviews are enough? An experiment with data saturation and variability. Field Meth 18:59-82, 2006
31. Ellis PM, Butow PN, Tattersall MHN, et al: Randomised clinical trials in oncology: Understanding and attitudes predict patients willingness to participate. J Clin Oncol 19:3554-3561, 2001 (Pubitemid 32730093)
32. Back AL, Arnold RM, Baile WF, et al: Efficacy of communication skills training for giving bad news and discussing transitions to palliative care. Arch Int Med 167:453-460, 2007 (Pubitemid 46425657)
33. Bartlett C, Doyal L, Ebrahim S, et al: The causes and effects of socio-demographic exclusions from clinical trials. Health Technol Assess 9:1-152, 2005
34. Branson RD, Davis KJ, Butler KL: African Americans participation in clinical research: Importance, barriers, and solutions. Am J Surg 193(1):32-9, 2007 (Pubitemid 44937148)
35. Swanson GM, Bailer JC 3rd: Selection and description of cancer clinical trials participants: Science or happenstance. Cancer 95:950-959, 2002 (Pubitemid 34925343)
36. Albrecht TL, Eggly SS, Gleeson ME, et al: Influence of clinical communication on patients' decision making on participation in clinical trials. J Clin Oncol 26: 2666-2673, 2008
37. Brown R, Bylund CL, Siminoff LA, et al: Seeking informed consent to phase I cancer clinical trial: Identifying oncologists' communication strategies. Psychooncology 20:361-368, 2010
38. Eggly S, Albrecht TL, Harper FWK, et al: Oncologists recommendations of clinical trial participation to patients. Patient Educ Couns 70:143-8, 2008 (Pubitemid 350256931)
39. Jenkins V, Fallowfield L, Solis-Trapala I, et al: Discussing randomised clinical trials of cancer therapy: Evaluation of a Cancer Research UK training programme. BMJ 330:400-406, 2005
40. Brown RF, Butow PN, Butt DG, et al: Developing ethical strategies to assist oncologist in seeking informed consent to cancer clinical trials. Soc Sci Med 58:379-390, 2004 (Pubitemid 37353050)
41. Scharff DP, Mathews KJ, Jackson P, et al: More than Tuskegee: Understanding mistrust about research participation. J Health Care Poor Underserved 21: 879-897, 2010
42. Grossman SA, Piantadosi S, Cohavey C: Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families? J Clin Oncol 12:2211-2215, 1994 (Pubitemid 24356041)
43. Meropol NJ, Weinfurt KP, Burnett CB, et al: Perceptions of patients and physicians regarding phase I cancer clinical trials: Implications for physician-patient communication. J Clin Oncol 21:2589-2596, 2003 (Pubitemid 46606342)
44. Cox K: Informed consent and decision making: Patients' experiences of the process of recruitment to phases 1 and 2 anti-cancer drug trials. Patient Educ Couns 46:31-38, 2002
45. Cheng JD, Hitt J, Koczwara B, et al: Impact of quality of life on patient expectations regarding phase I clinical trials. J Clin Oncol 18:421-428, 2000 (Pubitemid 30056433)
46. Daugherty C, Kass NE, Roter D, et al: A study of physician investigator (PI) disclosure of alternatives of care and prognostic information to advanced cancer patients (ACP) enrolling in phase I trials. J Clin Oncol 27, 2009 (suppl; abstr 6508)
47. Brown RF, Butow PN, Boyle F, et al: Seeking informed consent to cancer clinical trials: Evaluating the efficacy of communication skills training. Psychooncology 16:507-516, 2007 (Pubitemid 47039551)
48. Clayman ML, Roter D, Wissow LS, et al: Autonomy related behaviors of patient companions and their effect on decision making at activity in geriatric primary care. Soc Sci Med 60:1583-1591, 2005 (Pubitemid 40126442)
49. Ho A: Relational autonomy or undue pressure? Family's role in medical decision making. Scand J Caring Sci 22:128-135, 2008
50. Siminoff LA, Zyzanski SJ, Rose JH, et al: The cancer communication assessment tool for patients and families (CCAT-PF- a new measure). Psychooncology 17:1216-1224, 2008
51. Agrawal M, Grady C, Fairclough DL, et al: Patient decision making process regarding participation in phase I oncology research. J Clin Oncol 24:4479-4484, 2006 (Pubitemid 46630987)
52. Albrecht TL, Penner LA, Cline RJW, et al: Studying the process of clinical communication: Issues of context, concepts and research directions. J Health Commun 14:47-56, 2009
53. Albrecht TL, Ruckdeschel JC, Riddle DL, et al: Communication and decision making about cancer clinical trials. Patient Educ Couns 50:39-42, 2003 (Pubitemid 36593238)
54. Brown RF, Butow PN, Ellis P, et al: Seeking informed consent to cancer clinical trials: Describing current practice. Soc Sci Med 58:2445-2457, 2004 (Pubitemid 38476982)
55. Fallowfield L, Jenkins V, Farewell V, et al: Efficacy of a Cancer Research UK communication skills training model for oncologists: A randomised controlled trial. Lancet 359:650-6, 2002 (Pubitemid 34203764)
56. Fallowfield L: Can we improve the professional personal fulfilment of doctors in cancer medicine? Br J Cancer 71:1132-3, 1995
57. Brown RF, L BC, Li Y, Edgerson S, Butow PN: Testing the utility of a cancer clinical trial specific Question Prompt List (QPL-CT) during oncology consultations Patient Educ Couns 88:311-317, 2011
58. Brown RF, Shuk E, Butow PN, et al: Identifying patient information needs about cancer clinical trials using a question prompt list. Patient Educ Couns 84:69-77, 2011
59. Brown RF, Shuk E, Leighl N, et al: Enhancing decision making about participation in cancer clinical trials: Development of a question prompt list. Support Care Cancer 19:1227-1238, 2011
60. Juraskova I, Butow P, Lopez A, et al: Improving informed consent: Pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS -II DCIS). Health Expect 11:252-262, 2008